Splenic volume as a predictor of treatment response in patients with non-small cell lung cancer receiving immunotherapy

INTRODUCTION: The spleen is a lymphoid organ and we hypothesize that clinical benefit to immunotherapy may present with an increase in splenic volume during treatment. The purpose of this study was to investigate whether changes in splenic volume could be observed in those showing clinical benefit v...

Descripción completa

Detalles Bibliográficos
Autores principales: Castagnoli, Francesca, Doran, Simon, Lunn, Jason, Minchom, Anna, O’Brien, Mary, Popat, Sanjay, Messiou, Christina, Koh, Dow-Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262211/
https://www.ncbi.nlm.nih.gov/pubmed/35797413
http://dx.doi.org/10.1371/journal.pone.0270950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262211/
https://www.ncbi.nlm.nih.gov/pubmed/35797413
http://dx.doi.org/10.1371/journal.pone.0270950

Ejemplares similares